A Study to Train a Machine Learning Algorithm for an Evaluation of the Use of Biometric Data Captured at the Wrist for the Identification of Acute Opioid Use Events and the Quantification of Opioid Withdrawal in Opioid Dependent Individuals
Part of paid clinical trials in Wilmington, North Carolina.
- Sponsor
- OpiAID
- Study ID
- NCT07405398
- Status
- Recruiting
Conditions
- Treatment for Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Train and evaluate the accuracy and reliability of the Strength Band Platform in identifying acute opioid dosing events from time-stamped biometric data collected from wrist-worn devices. — DEVICESubjects will be fitted with the wearable device (Samsung Galaxy Watch) for the purpose of data communication and will be instructed to wear the device continuously, except when charging the watch, showering or any activity in which submersion in water is required. Participants will wear the device for 14 days. Study subjects will be responsible for: * Wearing the Samsung Galaxy watch daily except when charging the watch, showering or any activity in which submersion in water is required * Charging the Samsung Galaxy watch daily * Answering prompts on the Samsung Galaxy watch * Answering the daily SOWS questionnaire(s)
Study Details
To train a machine learning model/algorithm for an evaluation of the use of biometric data captured at the wrist for the identification of acute opioid use events and the quantification of opioid withdrawal in opioid dependent individuals.
Key Dates
- Start date
- May 1, 2025
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 420 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Single arm 14 day monitoring periodThe goal of this real-world, multi-center, outpatient study is to train a machine learning model/algorithm utilizing patient-specific physiological parameters from the OpiAID Strength Band Platform™ can accurately detect MOUD events during the induction phase with a predefined classification success when comparing the True Positive Rate against the False Positive Rate as plotted on a Receiver Operator Curve. In addition to MOUD detection, machine learning will be used to quantify participant withdrawal level from physiological parameters. To demonstrate that withdrawal quantification performs as well or better than current measures used for this purpose the correlation between quantified withdrawal and time since last opioid dose (TSLD) will be computed and compared against the association between SOWS and TSLD in a non-inferiority analysis. Prescribing physician must determine appropriate starting dose (titration expected over 2-6 weeks)
Primary Outcome Measure
Classification [ Time Frame: 14 days ]
Central Contacts
- Trace Brookins919.355.8221
- David Reeser484.824.2248
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Coastal Horizon | Wilmington | North Carolina | 28409 | Rebecca Wlasiuj |
| Community Medical Services | Austin | Texas | 78745 | Sabrie Satterwhite, PhD (PRINCIPAL_INVESTIGATOR) |
| Community Medical Services | Austin | Texas | 78753 | Sabrie Satterwhite, PhD (PRINCIPAL_INVESTIGATOR) |
| Community Medical Services | Cedar Park | Texas | 78613 | Sabrie Satterwhite, PhD (PRINCIPAL_INVESTIGATOR) |